Treatment of chronic allograft dysfunction with mycophenolate mofetil after kidney transplantation:a multicenter study / 中华器官移植杂志
Chinese Journal of Organ Transplantation
;
(12)1996.
Article
in Chinese
| WPRIM
| ID: wpr-539885
ABSTRACT
Objective To investigate the therapeutic effectiveness and safety of mycophenolate mofetil (MMF) in the treatment of chronic allograft dysfunction (CAD).Methods Seventy-eight patients with CAD were administrated with MMF substituting for Aza or CTX with concomitant low-dose CsA. The effectiveness and complications were analyzed. The mean follow-up time after MMF treatment was 9.48 months.Results After treatment with MMF in combination with low doses of CsA and Pred,the serum creatinine concentration (SCr) in 74 CAD patients was significantly decreased and remained stable at the end of follow-up ( P
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Controlled clinical trial
Language:
Chinese
Journal:
Chinese Journal of Organ Transplantation
Year:
1996
Type:
Article
Similar
MEDLINE
...
LILACS
LIS